Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
90 participants
INTERVENTIONAL
2023-01-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Childhood and Adolescent Migraine Prevention Study
NCT01581281
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children
NCT00237302
A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children
NCT00210535
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
NCT00963937
Zonisamide Versus Topiramate in Migraine
NCT06347497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
zolmitriptane
zolmitriptane tablet daily
zolmitriptanee
zolmitriptane tablet daily
topiramate
topiramate tablet daily
topiramate
topiramate once daily
valproate
valproate once daily
Valproate
valproate once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
zolmitriptanee
zolmitriptane tablet daily
topiramate
topiramate once daily
Valproate
valproate once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abeer Salamah, ass prof
Role: PRINCIPAL_INVESTIGATOR
kafrelsheikh university- egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kafrelsheikh University
Tanta, Kafrelsheikh, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
abeer salamah, ass prof
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
abeer salamah, lecturer
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Migraine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.